Insulet Corp. (PODD)
148.66
+3.53
(+2.43%)
USD |
NASDAQ |
Aug 31, 16:00
148.71
+0.05
(+0.03%)
After-Hours: 20:00
Insulet Cash from Operations (TTM) : 511.30M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 511.30M |
| March 31, 2026 | 619.30M |
| December 31, 2025 | 569.30M |
| September 30, 2025 | 533.70M |
| June 30, 2025 | 506.50M |
| March 31, 2025 | 406.50M |
| December 31, 2024 | 430.30M |
| September 30, 2024 | 327.50M |
| June 30, 2024 | 285.00M |
| March 31, 2024 | 232.50M |
| December 31, 2023 | 145.40M |
| September 30, 2023 | 151.20M |
| June 30, 2023 | 151.90M |
| March 31, 2023 | 133.20M |
| December 31, 2022 | 119.00M |
| September 30, 2022 | 42.80M |
| June 30, 2022 | -39.70M |
| March 31, 2022 | -46.70M |
| December 31, 2021 | -68.10M |
| September 30, 2021 | -43.60M |
| June 30, 2021 | 44.40M |
| March 31, 2021 | 52.50M |
| December 31, 2020 | 84.00M |
| September 30, 2020 | 131.93M |
| June 30, 2020 | 100.92M |
| Date | Value |
|---|---|
| March 31, 2020 | 88.43M |
| December 31, 2019 | 98.40M |
| September 30, 2019 | 81.91M |
| June 30, 2019 | 66.57M |
| March 31, 2019 | 46.53M |
| December 31, 2018 | 35.90M |
| September 30, 2018 | 27.26M |
| June 30, 2018 | 34.68M |
| March 31, 2018 | 58.78M |
| December 31, 2017 | 41.21M |
| September 30, 2017 | 39.48M |
| June 30, 2017 | 18.88M |
| March 31, 2017 | 4.593M |
| December 31, 2016 | 15.91M |
| September 30, 2016 | -22.75M |
| June 30, 2016 | -16.68M |
| March 31, 2016 | -19.58M |
| December 31, 2015 | -12.55M |
| September 30, 2015 | 10.65M |
| June 30, 2015 | 6.726M |
| March 31, 2015 | 6.449M |
| December 31, 2014 | 8.92M |
| September 30, 2014 | 0.795M |
| June 30, 2014 | -0.333M |
| March 31, 2014 | 3.531M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Abbott Laboratories | 9.905B |
| DexCom, Inc. | 1.749B |
| Boston Scientific Corp. | 4.529B |
| PROCEPT BioRobotics Corp. | -74.34M |
| Globus Medical, Inc. | 910.39M |